Development of the Core Outcome Set for Psychiatric Pharmacists

IF 1.3 Q4 PHARMACOLOGY & PHARMACY
Kristina Reinstatler Pharm.D., MBA, Gregory H. Payne MBA, Jonathan F. Lister Pharm.D., Tera D. Moore Pharm.D., Brittany L. Parmentier Pharm.D., MPH, Ranel Troy Santos Pharm.D., Carla D. Cobb Pharm.D.
{"title":"Development of the Core Outcome Set for Psychiatric Pharmacists","authors":"Kristina Reinstatler Pharm.D., MBA,&nbsp;Gregory H. Payne MBA,&nbsp;Jonathan F. Lister Pharm.D.,&nbsp;Tera D. Moore Pharm.D.,&nbsp;Brittany L. Parmentier Pharm.D., MPH,&nbsp;Ranel Troy Santos Pharm.D.,&nbsp;Carla D. Cobb Pharm.D.","doi":"10.1002/jac5.1917","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>The American Association of Psychiatric Pharmacists (AAPP) sought to develop a consensus-based set of outcomes and measures to standardize psychiatric pharmacy practice and research. The measures in this Core Outcome Set for Psychiatric Pharmacists (COS-PP) are designed to study the impact of psychiatric pharmacists caring for individuals living with psychiatric disorders.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The COS-PP was developed using guidelines from the Core Outcome Measures in Effectiveness Trials (COMET) initiative. A committee systematically reviewed a catalog of 194 articles and 40 posters that referenced psychiatric disorders, patient-level outcomes, and pharmacist interventions. From these initial 234 resources, 554 combinations of outcomes and measures were identified. Additional papers, guidelines, and feedback from experts increased the number to 592 combined outcomes and measures. The principal investigator consolidated the list to 46 potential outcomes. AAPP members were invited to complete a survey rating the 46 potential outcomes on five key factors: comprehensive, attributable to pharmacy, feasible, scientifically sound, and usable. These survey results were provided to the 18 Board-Certified Psychiatric Pharmacists participating in a summit examining the potential outcomes and measures gleaned from literature review. Through discussion and refinement, consensus was achieved on the final COS-PP.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The final COS-PP included 21 outcomes, 14 of which included at least 1 measure (84 total measures). The outcomes were grouped according to the quadruple health care aims: better care, reduced healthcare costs, improved patient experience, and improved clinician well-being.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>COS-PP will help define psychiatric pharmacists' support of the interdisciplinary team in addressing the quadruple health care aims. Using standardized outcomes across practice sites will allow aggregation of data on the impact of psychiatric pharmacists on patient care.</p>\n </section>\n </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1917","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1917","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The American Association of Psychiatric Pharmacists (AAPP) sought to develop a consensus-based set of outcomes and measures to standardize psychiatric pharmacy practice and research. The measures in this Core Outcome Set for Psychiatric Pharmacists (COS-PP) are designed to study the impact of psychiatric pharmacists caring for individuals living with psychiatric disorders.

Methods

The COS-PP was developed using guidelines from the Core Outcome Measures in Effectiveness Trials (COMET) initiative. A committee systematically reviewed a catalog of 194 articles and 40 posters that referenced psychiatric disorders, patient-level outcomes, and pharmacist interventions. From these initial 234 resources, 554 combinations of outcomes and measures were identified. Additional papers, guidelines, and feedback from experts increased the number to 592 combined outcomes and measures. The principal investigator consolidated the list to 46 potential outcomes. AAPP members were invited to complete a survey rating the 46 potential outcomes on five key factors: comprehensive, attributable to pharmacy, feasible, scientifically sound, and usable. These survey results were provided to the 18 Board-Certified Psychiatric Pharmacists participating in a summit examining the potential outcomes and measures gleaned from literature review. Through discussion and refinement, consensus was achieved on the final COS-PP.

Results

The final COS-PP included 21 outcomes, 14 of which included at least 1 measure (84 total measures). The outcomes were grouped according to the quadruple health care aims: better care, reduced healthcare costs, improved patient experience, and improved clinician well-being.

Conclusions

COS-PP will help define psychiatric pharmacists' support of the interdisciplinary team in addressing the quadruple health care aims. Using standardized outcomes across practice sites will allow aggregation of data on the impact of psychiatric pharmacists on patient care.

Abstract Image

制定精神科药剂师核心成果集
美国精神科药剂师协会 (American Association of Psychiatric Pharmacists, AAPP) 试图开发一套基于共识的结果和测量方法,以规范精神科药剂学实践和研究。这套精神科药剂师核心结果集 (COS-PP) 中的衡量标准旨在研究精神科药剂师对精神障碍患者的护理效果。COS-PP 是根据疗效试验核心结果衡量标准 (COMET) 计划的指导方针制定的。一个委员会系统地审查了目录中 194 篇文章和 40 张海报,这些文章和海报都提到了精神障碍、患者层面的结果以及药剂师的干预措施。从这最初的 234 项资源中,确定了 554 种结果和测量组合。更多的论文、指南和专家反馈将组合结果和措施的数量增加到 592 个。主要研究人员将该列表合并为 46 项潜在结果。AAPP 成员受邀完成了一项调查,根据以下五个关键因素对 46 项潜在结果进行评分:全面性、药学属性、可行性、科学性和可用性。这些调查结果提供给了参加峰会的 18 位获得委员会认证的精神科药剂师,峰会对潜在成果和从文献回顾中收集到的措施进行了研究。最终的 COS-PP 包括 21 项结果,其中 14 项至少包含一项衡量标准(总计 84 项衡量标准)。COS-PP 将有助于确定精神科药剂师对跨学科团队实现四重医疗保健目标的支持。使用跨实践地点的标准化结果将有助于汇总有关精神科药剂师对患者护理影响的数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信